Autoimmune Fetal Congenital Heart Block
| dc.contributor.author | Elrgeig, Hajer Khalil | |
| dc.date.accessioned | 2019-06-25T09:08:19Z | |
| dc.date.available | 2019-06-25T09:08:19Z | |
| dc.date.issued | 2019-04-26 | |
| dc.description | Autoimmune fetal Congenital heart block (CHB) is a severe, life-threatening disorder and the most severe manifestation of neonatal lupus, that associated with passive transfer of maternal anti-Ro/SSA and anti-La/SSB auto-antibodies that cross the placenta and bind to cardiomyocytes, and the atrioventricular (AV) conduction system is disrupted by inflammation with subsequent fibrosis and calcification leading to a complete AV block.(1,2) It is typically develops between 20 and 24 weeks of gestation | en_US |
| dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/975 | |
| dc.language.iso | en | en_US |
| dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.title | Autoimmune Fetal Congenital Heart Block | en_US |
| dc.type | Other | en_US |